Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells

Immunology

Volumn 143, Issue 3, 2014, Pages 363-373

  Eadon, Michael T ^a   Jacob, Alexander ^b   Cunningham, Patrick N ^c   Quigg, Richard J ^b   Garcia, Joe G N ^d   Alexander, Jessy J ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; Complement; Endothelial cells; Inflammation; Lupus; MicroRNA

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; MICRORNA; MICRORNA 133A; MICRORNA 193; MICRORNA 26B; MICRORNA 28; MICRORNA 320A; MICRORNA 423-3P; MICRORNA 509-5P; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; INFLAMMATION; LUPUS VULGARIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BRAIN; CELL CULTURE; CELL LINE; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PERMEABILITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE; CELLS, CULTURED; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICRORNAS; PERMEABILITY;

EID: 84908282983     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12314     Document Type: Article

References (63)

1. Davson H, Zlokovic BV, Rakic L, Segal MB. An Introduction to the Blood-Brain Barrier. London: Macmillan, 1993.
2. Abbott NJ, Mendonca LL, Dolman DE. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003; 12:908-15.
3. Jacob A, Hack B, Chiang E, Garcia JG, Quigg RJ, Alexander JJ. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J 2010; 24: 1682-8.
4. Jacob A, Hack B, Chen P, Quigg RJ, Alexander JJ. C5a/CD88 signaling alters blood- brain barrier integrity in lupus through nuclear factor-jB. J Neurochem 2011; 119:1041-51.
5. Alexander JJ, Jacob A, Bao L, MacDonald RL, Quigg RJ. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol 2005; 175:8312-9.
6. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology 2002; 205:395-406.
7. Morgan BP, Gasque P, Singhrao SK, Piddlesden SJ. Role of complement in inflammation and injury in the nervous system. Exp Clin Immunogenet 1997; 14:19-23.
8. Nicholson-Weller A, Halperin JA. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol Res 1993; 12:244-57.
9. Muller-Eberhard HJ, Schreiber RD. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol 1980; 29:1-53.
10. Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988; 57:321-47.
11. Barnum SR, Ames RS, Maycox PR, Hadingham SJ, Meakin J, Harrison D, Parsons AA. Expression of the complement C3a and C5a receptors after permanent focal ischemia: an alternative interpretation. Glia 2002; 38:169-73.
12. Stahel PF, Kossmann T, Morganti-Kossmann MC, Hans VH, Barnum SR. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Brain Res Mol Brain Res 1997; 50:205-12.
13. Albrecht EA, Chinnaiyan AM, Varambally S, Kumar-Sinha C, Barrette TR, Sarma JV, Ward PA. C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 2004; 164:849-59.
14. Beveridge NJ, Tooney PA, Carroll AP et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008; 17:1156-68.
15. Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in agerelated macular degeneration (AMD). Int J Biochem Mol Biol 2012; 3:105-16.
16. Ambros V. The evolution of our thinking about microRNAs. Nat Med 2008; 14:1036-40.
17. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97.
18. Chen K, Rajewsky N. Deep conservation of microRNA-target relationships and 30UTR motifs in vertebrates, flies, and nematodes. Cold Spring Harb Symp Quant Biol 2006; 71:149-56.
19. Filipowicz W. RNAi: the nuts and bolts of the RISC machine. Cell 2005; 122:17-20.
20. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455:58-63.
21. Guarnieri DJ, DiLeone RJ. MicroRNAs: a new class of gene regulators. Ann Med 2008; 40:197-208.
22. Matsubara H, Takeuchi T, Nishikawa E et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 2007; 26:6099-105.
23. Huang XH, Wang Q, Chen JS et al. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res 2009; 39:786-94.
24. Gauthier BR, Wollheim CB. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med 2006; 12:36-8.
25. Lu DP, Read RL, Humphreys DT, Battah FM, Martin DI, Rasko JE. PCR-based expression analysis and identification of microRNAs. J RNAi Gene Silencing 2005; 1:44-9.
26. Davis BN, Hata A. Regulation of microRNA biogenesis: a miRiad of mechanisms. Cell Commun Signal 2009; 7:18.
27. Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 2009; 33:422-8.
28. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317:1220-4.
29. Dharap A, Bowen K, Place R, Li LC, Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab 2009; 29:675-87.
30. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008; 39:959-66.
31. Sepramaniam S, Armugam A, Lim KY, Karolina DS, Swaminathan P, Tan JR, Jeyaseelan K. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J Biol Chem 2010; 285:29223-30.
32. Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, Ahmed SA. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 2010; 5:e14302.
33. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009; 29:749-54.
34. Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH, Xu ZM, Yin YB. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007; 16:939-46.
35. Rink C, Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics 2011; 43:521-8.
36. Lee Y, Ahn C, Han J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415-9.
37. Han Y, Liu Y, Gui Y, Cai Z. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. J Surg Oncol 2013; 107: 201-5.
38. Lehrbach NJ, Miska EA. Regulation of pre-miRNA processing. Adv Exp Med Biol 2010; 700:67-75.
39. Lee Y, Han J, Yeom KH, Jin H, Kim VN. Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol 2006; 71:51-7.
40. Lee Y, Kim VN. In vitro and in vivo assays for the activity of Drosha complex. Methods Enzymol 2007; 427:89-106.
41. Mitsuuchi Y, Powell DR, Gallo JM. Adenoviral modification of mouse brain derived endothelial cells, bEnd3, to induce apoptosis by vascular endothelial growth factor. Oncogene 2006; 25:954-8.
42. Gavrilyuk V, Kalinin S, Hilbush BS, Middlecamp A, McGuire S, Pelligrino D, Weinberg G, Feinstein DL. Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J Neurochem 2005; 92:1140-9.
43. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edgdependent cytoskeletal rearrangement. J Clin Invest 2001; 108:689-701.
44. Bernas MJ, Cardoso FL, Daley SK, Weinand ME, Campos AR. Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. Nat Protoc 2010; 5:1265-72.
45. Easton AS, Abbott NJ. Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier. Brain Res 2002; 953:157-69.
46. Schmittgen TD, Lee EJ, Jiang J. High-throughput real-time PCR. Methods Mol Biol 2008; 429:89-98.
47. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008; 3:1101-8.
48. Jacob A, Hensley LK, Safratowich BD, Quigg RJ, Alexander JJ. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab Invest 2007; 87:1186-94.
49. Jacob A, Hack B, Bai T, Brorson JR, Quigg RJ, Alexander JJ. Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol 2007; 221:46-52.
50. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14:419-27.
51. Chen C, Ridzon DA, Broomer AJ et al. Real-time quantification of microRNAs by stem RT-PCR. Nucleic Acids Res 2005; 33:179.
52. Karolina DS, Tavintharan S, Armugam A et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 2012; 97:E2271-6.
53. Yang R, Zheng T, Cai X et al. Genome-wide analyses of amphioxus microRNAs reveal an immune regulation via miR-92d targeting C3. J Immunol 2013; 190:1491-500.
54. Li YY, Alexandrov PN, Pogue AI, Zhao Y, Bhattacharjee S, Lukiw WJ. miRNA-155 upregulation and complement factor H deficits in Down's syndrome. NeuroReport 2012; 23:168-73.
55. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65:6029-33.
56. Lim LP, Lau NC, Garrett-Engele P et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73.
57. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9:839-45.
58. Fazi F, Nervi C. MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc Res 2008; 79:553-61.
59. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 2008; 105:1608-13.
60. Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell 2006; 24:157-63.
61. Bilen J, Liu N, Bonini NM. A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins. Cell Cycle 2006; 5:2835-8.
62. O'Carroll D, Schaefer A. General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology 2013; 38:39-54.
63. Schaefer A, O'Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R, Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 2007; 204:1553-8.